Ciming Checkup

About Ciming Checkup

Ciming Health Checkup Management Group operates as a significant provider of preventative healthcare and medical examination services within China. Founded in 2002 by Dr. Han Xiaohong, a former oncology physician at the Chinese PLA General Hospital, and her husband, Hu Bo, who serves as the chairman, the company was established on the medical principle of “early diagnosis, early detection, and early treatment”. Hu Bo holds a master's degree in medicine and previously worked in clinical roles and for organizations like the China Cancer Foundation and the China Medicinal Biotech Association before co-founding Ciming.

The company's core business is providing professional, chain-operated health check-up services. It pioneered a streamlined, assembly-line model for health screenings in China, a departure from the more fragmented hospital visits of the past. The service portfolio is extensive, covering health examinations, health management, the creation of health profiles, disease risk evaluation, and green-channel referrals for further medical treatment. Ciming serves a broad clientele, from individuals to corporate clients, and has developed premium service tiers, such as the OASIS International Wellness Club, which offers lifelong memberships and comprehensive services like private doctors and anti-aging treatments for high-net-worth individuals. The majority of its business is B2B, catering to corporate group clients.

Ciming generates revenue through its health check-up packages and value-added health management services. The company has expanded its offerings into the digital realm with a mobile app, "Jijiankang," which allows users to store and analyze their health data and receive professional advice. Strategically, Ciming has also moved into post-checkup health management, focusing on chronic diseases and leveraging AI and data to provide ongoing care, an area where it sees an advantage over public hospitals. In 2017, Ciming was acquired by a competitor, Meinian Onehealth Healthcare, creating a larger entity in China's health check-up market. The company has also invested in international medical tourism facilities in Hainan's Boao Lecheng International Medical Tourism Pilot Zone, aiming to provide advanced treatments, such as for chronic diseases and infertility, domestically.